These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9574781)
21. Development and application of an indirect enzyme-linked immunosorbent assay for serological survey of Japanese encephalitis virus infection in dogs. Shimoda H; Inthong N; Noguchi K; Terada Y; Nagao Y; Shimojima M; Takasaki T; Rerkamnuaychoke W; Maeda K J Virol Methods; 2013 Jan; 187(1):85-9. PubMed ID: 23046992 [TBL] [Abstract][Full Text] [Related]
22. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299 [TBL] [Abstract][Full Text] [Related]
23. Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus. Arakawa M; Yamashiro T; Uechi G; Tadano M; Nishizono A Microbiol Immunol; 2007; 51(6):617-25. PubMed ID: 17579273 [TBL] [Abstract][Full Text] [Related]
24. Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies. Gangwar RS; Shil P; Cherian SS; Gore MM Virus Res; 2011 Jun; 158(1-2):179-87. PubMed ID: 21477626 [TBL] [Abstract][Full Text] [Related]
25. Detection of antibodies against Japanese encephalitis virus in raccoons, raccoon dogs and wild boars in Japan. Ohno Y; Sato H; Suzuki K; Yokoyama M; Uni S; Shibasaki T; Sashika M; Inokuma H; Kai K; Maeda K J Vet Med Sci; 2009 Aug; 71(8):1035-9. PubMed ID: 19721354 [TBL] [Abstract][Full Text] [Related]
26. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs. García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A Viruses; 2017 May; 9(5):. PubMed ID: 28531165 [TBL] [Abstract][Full Text] [Related]
27. Early death of Japanese encephalitis virus-infected mice administered a neutralizing cross-reactive monoclonal antibody against glycoprotein E. Gupta AK; Lad VJ; Koshy AA Acta Virol; 2009; 53(3):191-5. PubMed ID: 19941401 [TBL] [Abstract][Full Text] [Related]
28. Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility. Kimura T; Kimura-Kuroda J; Nagashima K; Yasui K Arch Virol; 1994; 139(3-4):239-51. PubMed ID: 7832632 [TBL] [Abstract][Full Text] [Related]
29. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins. Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624 [TBL] [Abstract][Full Text] [Related]
30. Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42. Lin CW; Cheng CW; Yang TC; Li SW; Cheng MH; Wan L; Lin YJ; Lai CH; Lin WY; Kao MC Virus Res; 2008 Oct; 137(1):49-55. PubMed ID: 18588927 [TBL] [Abstract][Full Text] [Related]
31. Rab5 and Rab11 Are Required for Clathrin-Dependent Endocytosis of Japanese Encephalitis Virus in BHK-21 Cells. Liu CC; Zhang YN; Li ZY; Hou JX; Zhou J; Kan L; Zhou B; Chen PY J Virol; 2017 Oct; 91(19):. PubMed ID: 28724764 [TBL] [Abstract][Full Text] [Related]
32. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens. Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114 [TBL] [Abstract][Full Text] [Related]
33. Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models. Xu XG; Wang ZS; Zhang Q; Li ZC; Zhao HN; Li W; Tong DW; Liu HJ Vaccine; 2011 Jan; 29(4):636-43. PubMed ID: 21115062 [TBL] [Abstract][Full Text] [Related]
34. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses. Gupta AK; Lad VJ; Koshy AA Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP. Reynard O; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S372-8. PubMed ID: 26232760 [TBL] [Abstract][Full Text] [Related]
36. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. Fuller AO; Santos RE; Spear PG J Virol; 1989 Aug; 63(8):3435-43. PubMed ID: 2545914 [TBL] [Abstract][Full Text] [Related]
37. [Screen of a membrane protein molecule from Vero cells capable of binding Japanese encephalitis virus(JEV)]. Li Y; Shi Y; Ding TB; Xu ZK Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):431-3. PubMed ID: 20423648 [TBL] [Abstract][Full Text] [Related]
38. [Preparation and characterization of the monoclonal antibodies against Japanese encephalitis virus.]. Wang L; Fu SH; Li X; Niu XL; Tang Q; Liang GD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Sep; 20(3):209-12. PubMed ID: 17086272 [TBL] [Abstract][Full Text] [Related]
39. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353 [TBL] [Abstract][Full Text] [Related]
40. Biological activities of the structural proteins of Japanese encephalitis virus. Takegami T; Miyamoto H; Nakamura H; Yasui K Acta Virol; 1982 Sep; 26(5):312-20. PubMed ID: 6128900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]